Dermatomyositis

Dermatomyositis is one of a group of muscle diseases known as the inflammatory myopathies, which are characterized by chronic muscle inflammation accompanied by muscle weakness.
What is Dermatomyositis?

Dermatomyositis is an inflammatory condition characterized by muscle weakness and a skin rash. Although the disease primarily affects the muscles and skin, it is a systemic condition and can also involve the lungs, joints, esophagus and sometimes the heart.

Read More

Overview

Feature Articles

Latest Dermatomyositis News and Research

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

Study shows ADA2 is a sensitive, specific biomarker for macrophage activation syndrome

Patients and families gather to gain more awareness, knowledge about myositis

Patients and families gather to gain more awareness, knowledge about myositis

New classification criteria offers faster, more accurate path to diagnosing myositis diseases

New classification criteria offers faster, more accurate path to diagnosing myositis diseases

Endurance training can be helpful in dealing with muscle inflammation

Endurance training can be helpful in dealing with muscle inflammation

New treatment reduces disease burden in patients with rare dermatologic condition

New treatment reduces disease burden in patients with rare dermatologic condition

Exoskeleton device helps man with disabling condition to complete 10K race

Exoskeleton device helps man with disabling condition to complete 10K race

Statin medications can cause necrotizing myopathy in some patients

Statin medications can cause necrotizing myopathy in some patients

Researchers develop ultrasensitive method to detect protein involved in autoimmune diseases

Researchers develop ultrasensitive method to detect protein involved in autoimmune diseases

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Anti-TNF therapy offers new hope to JDM patients

Anti-TNF therapy offers new hope to JDM patients

African-American patients with connective tissue diseases at risk for cardiovascular disease

African-American patients with connective tissue diseases at risk for cardiovascular disease

Idera begins enrollment in IMO-8400 Phase 2 clinical trial for treatment of dermatomyositis

Idera begins enrollment in IMO-8400 Phase 2 clinical trial for treatment of dermatomyositis

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Former all-American wrestler speaks about his personal battle with chronic muscle disease

Former all-American wrestler speaks about his personal battle with chronic muscle disease

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Idera collaborates with TMA to advance new potential treatment approach for myositis

Idera collaborates with TMA to advance new potential treatment approach for myositis

Baylor receives $3.3M grant from NIAMS to advance research in autoimmune diseases

Baylor receives $3.3M grant from NIAMS to advance research in autoimmune diseases

Idera Pharmaceuticals reports positive top-line results from Phase 2 trial of IMO-8400

Idera Pharmaceuticals reports positive top-line results from Phase 2 trial of IMO-8400

Researchers create specific tests to detect cancer biomarkers in patients with dermatomyositis

Researchers create specific tests to detect cancer biomarkers in patients with dermatomyositis

Questcor acquires rights to develop Synacthen and Synacthen Depot in US

Questcor acquires rights to develop Synacthen and Synacthen Depot in US